These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15065503)

  • 1. [Mast cells in coronary arteries-an immune cell at a wrong address?].
    Kovanen P
    Duodecim; 2004; 120(2):126-37. PubMed ID: 15065503
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery.
    Laine P; Kaartinen M; Penttilä A; Panula P; Paavonen T; Kovanen PT
    Circulation; 1999 Jan; 99(3):361-9. PubMed ID: 9918522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogenic immune response promotes the accumulation of host-derived smooth muscle cells in transplant arteriosclerosis.
    Religa P; Bojakowski K; Bojakowska M; Gaciong Z; Thyberg J; Hedin U
    Cardiovasc Res; 2005 Feb; 65(2):535-45. PubMed ID: 15639493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherogenesis: current understanding of the causes of atheroma.
    Weissberg PL
    Indian Heart J; 2000; 52(4):467-72. PubMed ID: 11084797
    [No Abstract]   [Full Text] [Related]  

  • 5. T cell recognition and killing of vascular smooth muscle cells in acute coronary syndrome.
    Pryshchep S; Sato K; Goronzy JJ; Weyand CM
    Circ Res; 2006 May; 98(9):1168-76. PubMed ID: 16601227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are neointimal smooth muscle cells in human cardiac allograft vasculopathy of donor origin?
    Beranek JT
    J Heart Lung Transplant; 2005 Aug; 24(8):1121-2. PubMed ID: 16102451
    [No Abstract]   [Full Text] [Related]  

  • 7. Apoptosis in human atherosclerosis and restenosis.
    Kockx M; De Meyer G
    Circulation; 1996 Jan; 93(2):394-5. PubMed ID: 8548916
    [No Abstract]   [Full Text] [Related]  

  • 8. Atherosclerotic abdominal aortic aneurysm and the interaction between autologous human plaque-derived vascular smooth muscle cells, type 1 NKT, and helper T cells.
    Chan WL; Pejnovic N; Hamilton H; Liew TV; Popadic D; Poggi A; Khan SM
    Circ Res; 2005 Apr; 96(6):675-83. PubMed ID: 15731463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries.
    Shinohara M; Kawashima S; Yamashita T; Takaya T; Toh R; Ishida T; Ueyama T; Inoue N; Hirata K; Yokoyama M
    Cardiovasc Res; 2005 Nov; 68(2):249-58. PubMed ID: 16039635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries.
    Parry TJ; Brosius R; Thyagarajan R; Carter D; Argentieri D; Falotico R; Siekierka J
    Eur J Pharmacol; 2005 Nov; 524(1-3):19-29. PubMed ID: 16271360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells.
    Rakesh K; Agrawal DK
    Int Immunopharmacol; 2005 Sep; 5(10):1487-506. PubMed ID: 16023601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of IGF-1R in stretch-induced neointimal hyperplasia in venous grafts.
    Song H; Mowbray AL; Sykes MC; Jo H
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1679-81. PubMed ID: 17634521
    [No Abstract]   [Full Text] [Related]  

  • 13. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
    Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
    Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells: multipotent local effector cells in atherothrombosis.
    Kovanen PT
    Immunol Rev; 2007 Jun; 217():105-22. PubMed ID: 17498055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical atherosclerosis, carotid intima-media thickness and the cardiovascular risk.
    Rugină M; Ciobanu-Jurcuţ R; Jurcuţ C; Mihăilă M; Apetrei E
    Rom J Intern Med; 2003; 41(4):357-63. PubMed ID: 15526519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
    Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
    Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts of the pathogenesis of the acute coronary syndromes.
    Libby P
    Circulation; 2001 Jul; 104(3):365-72. PubMed ID: 11457759
    [No Abstract]   [Full Text] [Related]  

  • 18. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
    Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis.
    Sasaguri Y; Wang KY; Tanimoto A; Tsutsui M; Ueno H; Murata Y; Kohno Y; Yamada S; Ohtsu H
    Circ Res; 2005 May; 96(9):974-81. PubMed ID: 15831815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse origin of intimal cells: smooth muscle cells, myofibroblasts, fibroblasts, and beyond?
    Zalewski A; Shi Y; Johnson AG
    Circ Res; 2002 Oct; 91(8):652-5. PubMed ID: 12386139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.